文献速递眼底病与葡萄膜炎小儿眼科与斜弱视青光眼

非葡萄膜炎性儿童患者行Tenon囊下曲安奈德注射后激素相关高眼压与白内障形成的发生率

INCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS.
PubMed 文献 · Retina · 2025-01-01

多中心回顾性病例系列纳入41例(59眼)接受Tenon囊下曲安奈德注射的非葡萄膜炎性儿童患者,剂量4-20mg,最常见诊断为早产儿视网膜病变(43.9%)。仅2眼(3.4%)为轻度激素反应者、1眼(1.7%)为中度反应者,无高反应者,所有眼压升高均在下次随访时恢复正常且无需降眼压药物;仅1眼(1.7%)出现微量后囊下白内障。

要点

  • 41例(59眼)中轻度激素反应者2眼(3.4%)、中度1眼(1.7%),无高反应者。
  • 所有激素反应者眼压均在下次随访时恢复正常,未使用降眼压药物。
  • 仅1眼(1.7%)出现微量后囊下白内障,无青光眼诊断或手术。

核心结论

  • Tenon囊下曲安奈德注射在儿童患者中相对于眼压升高和白内障形成具有有利的安全性特征。
  • 无需降眼压药物或手术干预。

研究设计与样本

  • 多中心、回顾性病例系列,纳入2018年11月至2023年10月期间三家三级眼科服务机构接受Tenon囊下曲安奈德注射的儿童患者。
  • 共识别392例患者,最终纳入41例患者的59眼(10.5%)。

主要发现

  • 激光治疗占95.1%的病例,Tenon囊下曲安奈德剂量范围为4至20mg,最常见诊断为早产儿视网膜病变(43.9%)。
  • 2眼(3.4%)为轻度激素反应者,对应2例患者(4.9%);1眼(1.7%)为中度激素反应者,对应1例患者(2.4%);无高激素反应者。
  • 所有出现激素反应的眼在下次随访时眼压均恢复正常范围,无需任何降眼压药物。
  • 无患者被诊断为青光眼或需要青光眼手术;仅1眼(1.7%)出现微量后囊下白内障,未观察到视盘杯凹或炎症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe intraocular pressure changes after injection of sub-Tenon triamcinolone during examination under anesthesia for pediatric patients. METHODS: Multicenter, retrospective case series of pediatric patients who received sub-Tenon triamcinolone from three tertiary care ophthalmic services between November 2018 and October 2023. RESULTS: Of 392 patients identified, 59 eyes (10.5%) of 41 patients were included. Laser was administered in 95.1% of the cases. Sub-Tenon triamcinolone dose ranged from 4 to 20 mg. The most common diagnosis was retinopathy of prematurity (43.9%). Two eyes (3.4%) of two patients (4.9%) were mild steroid responders. One eye (1.7%) of 1 patient (2.4%) was a moderate responder. There were no high steroid responders, and all eyes with steroid response showed a return of intraocular pressure to normal range at next visit without needing any intraocular pressure-lowering medications. No patients were diagnosed with glaucoma or required glaucoma surgery. Only 1 eye (1.7%) developed trace posterior subcapsular cataract, whereas no optic disk cupping or inflammation were noted. CONCLUSION: Sub-Tenon triamcinolone injection is commonly used to prevent inflammation at the time of retinal photocoagulation treatment in pediatric patients. It has a favorable safety profile in relation to intraocular pressure elevation and cataract formation. There was no requirement for intraocular pressure-lowering medications or surgical interventions.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Patel NA, Hoyek S, López-Font FJ, et al. INCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS. Retina. 2025. PMID: 39316833. doi:10.1097/IAE.0000000000004272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。